Background
Glu89Gln transthyretin (TTR) variant is a well-known cause of systemic amyloidosis with a cardiologic, neurologic or mixed phenotype. Even though Glu89Gln transthyretin (TTR) variant has been described worldwide, it remains unknown whether geographical area influences the phenotypic expression of the disease (as happens with the Val30Met mutation, which is known to manifest with different phenotypes in different geographical contexts). We hypothesized that significant phenotypic differences exist between patients with Glu89Gln-related amyloidosis according to the specific geographic origin.
Methods
We retrospectively analysed and compared the clinical, electrocardiographic and echocardiographic findings of 64 patients with Glu89Gln TTR-related amyloidosis from Italy and Bulgaria.
Results
Despite a similar age at diagnosis of the disease (55 [ 
Conclusion
This is the largest series so far of patients with Glu89Gln TTR-related amyloidosis systematically analysed. Overall, disease onset is late with a mixed phenotypic expression.
Despite a similar age at onset and a predominance of neurological routes, Bulgarian patients showed a more pronounced cardiomyopathy. 
